Haemonetics Corporation (HAE) Q3 2023 Earnings Results

Haemonetics Corp Beats on EPS, Stock Down 5.9%

Haemonetics Corp reported better-than-expected earnings per share, but the stock fell by 5.9% following the announcement. The decline may be attributed to concerns raised during the earnings call regarding market challenges and the lack of revenue data. Investors might be cautious as the company navigates these uncertainties without updated guidance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.85	N/A	+7.59%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concerns about market conditions affecting performance. They are prioritizing efficiency to navigate these challenges.

Management highlighted ongoing challenges in the market.

They emphasized a focus on operational efficiency moving forward.

Haemonetics Corp Beats on EPS, Stock Down 5.9%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Beats on EPS, Stock Down 5.9%

Key numbers

Management commentary